Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.33% | -32.65% | -8.60% | -23.10% | 10.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.33% | -32.65% | -8.60% | -23.10% | 10.04% |
| Operating Income | 40.33% | 32.65% | 8.60% | 23.10% | -35.55% |
| Income Before Tax | -157.89% | 49.37% | 7.50% | 21.66% | 1.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -157.89% | 49.37% | 7.50% | 21.66% | 1.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -157.89% | 49.37% | 7.50% | 21.66% | 1.68% |
| EBIT | 40.33% | 32.65% | 8.60% | 23.10% | -35.55% |
| EBITDA | 41.33% | 33.50% | 8.68% | 23.60% | -36.46% |
| EPS Basic | 53.55% | 90.88% | 83.52% | 74.46% | 13.95% |
| Normalized Basic EPS | 65.84% | 87.80% | 83.52% | 74.46% | -17.02% |
| EPS Diluted | 53.55% | 90.88% | 83.52% | 74.46% | 13.95% |
| Normalized Diluted EPS | 65.84% | 87.80% | 83.52% | 74.46% | -17.02% |
| Average Basic Shares Outstanding | 455.19% | 454.77% | 461.10% | 206.75% | 14.24% |
| Average Diluted Shares Outstanding | 455.19% | 454.77% | 461.10% | 206.75% | 14.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |